4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-22-049213
Chief Executive Officer acquired 3,125 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2022-03-15 | Grant or award | +3,125 | $8.53 | $26,642 | 1,699,468 | D |
| Derivatives | |||||||
| Harris Todd Chief Executive Officer | 2022-09-06 | Grant or award · Stock Option (Right to Buy) | +270,000 | 270,000 | D | ||
Loading xslF345X03/doc4.xml…